Literature DB >> 32363922

Mutations in MC4R facilitate the angiogenic activity in patients with orbital venous malformation.

Xiao-Ming Huang1,2,3, Wan-Chen Yang1,2, Yang Liu3, Dong-Run Tang1,2, Tong Wu1,2, Feng-Yuan Sun1,2.   

Abstract

IMPACT STATEMENT: The detailed molecular mechanism of orbital venous malformation (OVM) is still not clear. Using whole exome sequencing, 4 types of melanocortin 4 receptor (MC4R) mutation were detected in 7 of 27 patients with OVM, and all types of MC4R mutations resulted in the upregulation of MC4R expression. In vitro study indicated that MC4R has impacts on the proliferation, cell cycle, migration, and tube formation of the endothelial cells. Moreover, MC4R mutations altered the downstream signaling, including cAMP concentration and the expression levels of several PI3K/AKT/mTOR downstream genes, including p21, cyclin B1, ITGA10, and ITGA11. MC4R mutations may lead to the pathogenesis of OVM through modulating the downstream signaling to alter the angiogenic activity of endothelial cells.

Entities:  

Keywords:  Orbital venous malformation; endothelial cells; melanocortin 4 receptor

Mesh:

Substances:

Year:  2020        PMID: 32363922      PMCID: PMC7427181          DOI: 10.1177/1535370220919056

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  39 in total

1.  A somatic MAP3K3 mutation is associated with verrucous venous malformation.

Authors:  Javier A Couto; Matthew P Vivero; Harry P W Kozakewich; Amir H Taghinia; John B Mulliken; Matthew L Warman; Arin K Greene
Journal:  Am J Hum Genet       Date:  2015-02-26       Impact factor: 11.025

Review 2.  In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.

Authors:  Anne M Goodwin
Journal:  Microvasc Res       Date:  2007-06-06       Impact factor: 3.514

3.  Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.

Authors:  M Vikkula; L M Boon; K L Carraway; J T Calvert; A J Diamonti; B Goumnerov; K A Pasyk; D A Marchuk; M L Warman; L C Cantley; J B Mulliken; B R Olsen
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

4.  Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas").

Authors:  Pascal Brouillard; Laurence M Boon; John B Mulliken; Odile Enjolras; Michella Ghassibé; Matthew L Warman; O T Tan; Bjorn R Olsen; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

5.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.

Authors:  I Kim; H G Kim; J N So; J H Kim; H J Kwak; G Y Koh
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

6.  Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration.

Authors:  N Jones; Z Master; J Jones; D Bouchard; Y Gunji; H Sasaki; R Daly; K Alitalo; D J Dumont
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

8.  Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis.

Authors:  Olivier Gavet; Jonathon Pines
Journal:  Dev Cell       Date:  2010-04-20       Impact factor: 12.270

9.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

10.  Overexpression and functional characterisation of the human melanocortin 4 receptor in Sf9 cells.

Authors:  Viveka Dolby; Anna Collén; Andreas Lundqvist; Philippe Cronet
Journal:  Protein Expr Purif       Date:  2004-10       Impact factor: 1.650

View more
  1 in total

1.  Comprehensive circular RNA expression profiling with associated ceRNA network in orbital venous malformation.

Authors:  Jie Yu; Peiwei Chai; Yixiong Zhou; Renbing Jia; Yefei Wang
Journal:  Mol Vis       Date:  2022-05-20       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.